FDA is alerting patients and health care professionals about the voluntary withdrawal of Oxbryta from the market due to safety concerns
[9/26/2024] FDA is alerting patients, caregivers, and health care professionals that Oxbryta (voxelotor)...
Cholesterol: Comparing the risks, safety of rosuvastatin, atorvastatin
Share on PinterestTwo widely used statins may be equally effective at preventing heart attacks and stroke....